Medical Facilities (DR) Q3 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2025 earnings summary
13 Nov, 2025Executive summary
Facility service revenue rose 7.5% year-over-year to $82.6 million, driven by higher surgical case volumes, favorable payor mix, and rate increases, with a notable rebound at Sioux Falls Specialty Hospital.
Income from operations increased 28.4% to $12.2 million; EBITDA grew 17.7% to $16.1 million, excluding prior year government stimulus.
Both Sioux Falls and Arkansas hospitals received five-star ratings for nurse communications in September.
$5.6 million was returned to shareholders through the repurchase of 514,200 shares under the NCIB.
Surgical case volumes increased 1.1% year-over-year, with outpatient cases up 3.3% and a rebound at Sioux Falls Specialty Hospital.
Financial highlights
Net income from continuing operations was $12.9 million for Q3 2025, down 7.6% year-over-year; for the nine months, net income rose 51.9% to $31.5 million.
Basic EPS for Q3 2025 was $0.44, up 91.3% year-over-year; for the nine months, basic EPS was $0.83, up 538.5%.
Operating expenses before non-cash share-based compensation increased 6.0% to $70.7 million in Q3 2025.
Distributable cash flow for Q3 2025 was C$4.7 million, with a payout ratio of 35.2%.
Quarterly cash dividend of C$0.09 per share, annualized yield of 2.55% on September 30, 2025 closing price.
Segment performance
Pain management volumes were negatively impacted by physician turnover, with new hires expected to improve future performance.
Drugs and supplies costs rose 10.5% due to higher acuity procedures, partially offset by implant cost savings and vendor rebates.
G&A expenses decreased 4.9% due to lower share-based compensation and professional fees, offset by higher recruiting and maintenance costs.
Specialty surgical hospitals in Arkansas, Oklahoma, and South Dakota, and an ambulatory surgery center in California, contributed to revenue growth.
Consolidated results exclude Black Hills Surgical Hospital, which was treated as discontinued operations in prior periods.
Latest events from Medical Facilities
- Strong revenue and earnings growth, major asset sales, and buybacks boosted shareholder returns.DR
Q4 202512 Mar 2026 - Revenue and EBITDA rose on strong case volumes; PPP loan forgiveness to boost Q3.DR
Q2 20242 Feb 2026 - Q3 net income up 263% and revenue up 11.2%, driven by PPP loan forgiveness and case growth.DR
Q3 202416 Jan 2026 - Net income nearly doubled in 2024, fueled by asset sales and robust capital returns.DR
Q4 202426 Dec 2025 - Revenue and EBITDA stable, net income up, and $44.3M returned to shareholders via buybacks.DR
Q1 202525 Nov 2025 - Q2 saw SFSH headwinds but strong net income growth and new $40M credit secured.DR
Q2 202523 Nov 2025